• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAclarion
    Picture of Aclarion logo

    ACON — Aclarion News Story

    $3.120.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    • Market Cap
      $7.68m
    • Enterprise Value
      -$11.32m
    • Revenue
      $0.08m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ACON Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ACON Dividends
    All News

    NASDAQ RESUMED AT 10:53 AM

    Picture of Aclarion logoAclarion
    22/04/2022 15:53
    NASDAQ RESUMED  ACONW.O  AT 10:53 AM
    

    Recent news on Aclarion

    See all news
    • Brief: Aclarion Provides Update On Strength Of Company Positioning Following Q1 Strategic Initiatives

      31/03/2025 12:11
    • Brief: Aclarion Announces Reverse Stock Split

      26/03/2025 11:47
    • Brief: Aclarion provides shareholder update, to file 10K by March-end

      13/03/2025 15:00
    • U.S. STOCKS ON THE MOVE-Fastenal, Target Hospitality , Encore Capital

      06/03/2025 18:48
    • Brief: Aclarion Announces Expansion Plans With RadNet Affiliates In New York And New Jersey

      06/03/2025 16:28

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.